{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T15:56:56Z","timestamp":1783612616307,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Some previous studies have indicated that valproate (VPA) might change the pharmacokinetics and enhance the effects of propofol. We evaluated whether clinical VPA therapy affected the propofol blood level, the protein-unbound free propofol level, and\/or the anesthetic effects of propofol in the clinical setting. The subjects were divided into the control group (not medicated with antiepileptics), the mono-VPA group (medicated with VPA alone), and the poly-VPA group (medicated with VPA, other antiepileptics, and\/or psychoactive drugs). General anesthesia was induced via the administration of a single bolus of propofol and a remifentanil infusion, and when the bispectral index (BIS) exceeded 60 sevoflurane was started. There were no significant differences in the total blood propofol level at 5, 10, 15, and 20\u2009min or the protein-unbound free propofol level at 5\u2009min after the intravenous administration of propofol between the 3 groups. However, the minimum BIS was significantly lower and the time until the BIS exceeded 60 was significantly longer in the poly-VPA group. In the multivariate regression analysis, belonging to the poly-VPA group was found to be independently associated with the minimum BIS value and the time until the BIS exceeded 60. Clinical VPA therapy did not influence the pharmacokinetics of propofol. However, multi-drug therapy involving VPA might enhance the anesthetic effects of propofol.<\/jats:p>","DOI":"10.1038\/s41598-020-58460-2","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T11:02:58Z","timestamp":1580468578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Multi-drug therapy for epilepsy influenced bispectral index after a bolus propofol administration without affecting propofol\u2019s pharmacokinetics: a prospective cohort study"],"prefix":"10.1038","volume":"10","author":[{"given":"Matsuri","family":"Kodama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minako","family":"Ishii-Maruhama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Honda-Wakasugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,31]]},"reference":[{"key":"58460_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.seizure.2015.03.016","volume":"29","author":"J Robertson","year":"2015","unstructured":"Robertson, J., Hatton, C., Emerson, E. & Baines, S. Prevalence of epilepsy among people with intellectual disabilities: A systematic review. Seizure 29, 46\u201362 (2015).","journal-title":"Seizure"},{"key":"58460_CR2","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","volume":"16","author":"E Perucca","year":"2002","unstructured":"Perucca, E. Pharmacological and Therapeutic Properties of Valproate. CNS Drugs 16, 695\u2013714 (2002).","journal-title":"CNS Drugs"},{"key":"58460_CR3","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1111\/j.1528-1167.2011.03328.x","volume":"53","author":"M Ishii","year":"2012","unstructured":"Ishii, M. et al. The influence of oral VPA on the required dose of propofol for sedation during dental treatment in patients with mental retardation: A prospective observer-blinded cohort study. Epilepsia. 53, e13\u2013e16 (2012).","journal-title":"Epilepsia."},{"key":"58460_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2147\/NDT.S59375","volume":"10","author":"G H\u0131zl\u0131 Sayar","year":"2014","unstructured":"H\u0131zl\u0131 Sayar, G., Ery\u0131lmaz, G., Semieo\u011flu, S., Ozten, E. & G\u00f6\u011fceg\u00f6z G\u00fcl, I. Influence of valproate on the required dose of propofol for anesthesia during electroconvulsive therapy of bipolar affective disorder patients. Neuropsychiatr. Dis. Treat. 10, 433\u2013438 (2014).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"58460_CR5","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/bja\/64.6.734","volume":"64","author":"K Leslie","year":"1990","unstructured":"Leslie, K. & Crankshaw, D. P. Potency of propofol for loss of consciousness after a single dose. Br. J. Anaesth. 64, 734\u2013736 (1990).","journal-title":"Br. J. Anaesth."},{"key":"58460_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/bja\/67.1.49","volume":"67","author":"T Gin","year":"1991","unstructured":"Gin, T. et al. Disposition of propofol at caesarean section and in the postpartum period. Br. J. Anaesth. 67, 49\u201353 (1991).","journal-title":"Br. J. Anaesth."},{"key":"58460_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0009-8981(85)90082-8","volume":"151","author":"TC Kwong","year":"1985","unstructured":"Kwong, T. C. Free drug measurements: methodology and clinical significance. Clin. Chim. Acta. 151, 193\u2013216 (1985).","journal-title":"Clin. Chim. Acta."},{"key":"58460_CR8","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s00540-018-2540-6","volume":"32","author":"M Ishii-Maruhama","year":"2018","unstructured":"Ishii-Maruhama, M. et al. In vitro changes in the proportion of protein-unbound-free propofol induced by valproate. J. Anesth. 32, 688\u2013693 (2018).","journal-title":"J. Anesth."},{"key":"58460_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1046\/j.0306-5251.2001.01474.x","volume":"52","author":"X Wen.","year":"2001","unstructured":"Wen., X., Wang, J.-S., Kivist\u00f6, K. T., Neuvonen, P. J. & Backman, J. T. In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9). Br. J. Clin. Pharmacol. 52, 547\u2013553 (2001).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"58460_CR10","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/S0006-2952(03)00076-5","volume":"65","author":"BT Ethell","year":"2003","unstructured":"Ethell, B. T., Anderson, G. D. & Burchell, B. The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP-glucuronosyltransferases. Biochem. Pharmacol. 65, 1441\u20131449 (2003).","journal-title":"Biochem. Pharmacol."},{"key":"58460_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","volume":"9","author":"CU Johannessen","year":"2003","unstructured":"Johannessen, C. U. & Johannessen, S. I. Valproate: past, present, and future. CNS Drug. Rev. 9, 199\u2013216 (2003).","journal-title":"CNS Drug. Rev."},{"key":"58460_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1177\/0004563215608875","volume":"53","author":"K Ichihara","year":"2016","unstructured":"Ichihara, K. et al. Committee on Common Reference Intervals, Japan Society of Clinical Chemistry. Collaborative derivation of reference intervals for major clinical laboratory tests in Japan. Ann. Clin. Biochem. 53, 347\u201356 (2016).","journal-title":"Ann. Clin. Biochem."},{"key":"58460_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/jir.12448","volume":"62","author":"H Higuchi","year":"2018","unstructured":"Higuchi, H. et al. Intellectual disability is a risk factor for delayed emergence from total intravenous anaesthesia. J. Intellect. Disabil. Res. 62, 217\u2013224 (2018).","journal-title":"J. Intellect. Disabil. Res."},{"key":"58460_CR14","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/00000542-200003000-00017","volume":"92","author":"J Sch\u00fcttler","year":"2000","unstructured":"Sch\u00fcttler, J. & Ihmsen, H. Population pharmacokinetics of propofol: a multicenter study. Anesthesiology. 92, 727\u201338 (2000).","journal-title":"Anesthesiology."},{"key":"58460_CR15","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1097\/00000542-200212000-00011","volume":"97","author":"DS Ward","year":"2002","unstructured":"Ward, D. S., Norton, J. R., Guivarc\u2019h, P. H., Litman, R. S. & Bailey, P. L. Pharmacodynamics and pharmacokinetics of propofol in a medium-chain triglyceride emulsion. Anesthesiology. 97, 1401\u20138 (2002).","journal-title":"Anesthesiology."},{"key":"58460_CR16","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s40262-018-0672-3","volume":"57","author":"MM Sahinovic","year":"2018","unstructured":"Sahinovic, M. M., Struys, M. M. R. F. & Absalom, A. R. Clinical Pharmacokinetics and Pharmacodynamics of Propofol. Clin. Pharmacokinet. 57, 1539\u20131558 (2018).","journal-title":"Clin. Pharmacokinet."},{"key":"58460_CR17","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.clinthera.2008.08.011","volume":"30","author":"KY Yap","year":"2008","unstructured":"Yap, K. Y., Chui, W. K. & Chan, A. Drug Interactions between Chemotherapeutic Regimens and Antiepileptics. Clin. Ther. 30, 1385\u20131407 (2008).","journal-title":"Clin. Ther."},{"key":"58460_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1046\/j.1528-1157.2002.13001.x","volume":"43","author":"PN Patsalos","year":"2002","unstructured":"Patsalos, P. N., Fr\u00f6scher, W., Pisani, F. & van Rijn, C. M. The importance of drug interactions in epilepsy therapy. Epilepsia. 43, 365\u2013385 (2002).","journal-title":"Epilepsia."},{"key":"58460_CR19","doi-asserted-by":"publisher","first-page":"933","DOI":"10.2217\/bmm-2017-0184","volume":"11","author":"A Smits","year":"2017","unstructured":"Smits, A., Annaert, P. & Allegaert, K. Biomarkers of propofol metabolism in neonates: the quest beyond ontogeny. Biomark Med. 11, 933\u2013936 (2017).","journal-title":"Biomark Med."},{"key":"58460_CR20","unstructured":"Smith, M. D., Metcalf, C. S. & Wilcox K. S. Pharmacotherapy of Epilepsies, 13th edition. [Brunton, L. L., Hilal-Dandan, R. & Knollmann, B. C. (eds)] Goodman & Gilman\u2019s: The Pharmacological Basis of Therapeutics. 17, 309 and 313 (McGraw-Hill Education New York, 2018)."},{"key":"58460_CR21","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/BF02244986","volume":"114","author":"G Mannens","year":"1994","unstructured":"Mannens, G., Meuldermans, W., Snoeck, E. & Heykants, J. Plasma protein binding of risperidone and its distribution in blood. Psychopharmacol. 114, 566\u2013572 (1994).","journal-title":"Psychopharmacol."},{"key":"58460_CR22","unstructured":"Vuyk, J., Sitsen, E. & Reekers, M. Intravenous Anesthetics, Eighth Edition [Miller, R. D. et al. (eds)] Miller\u2019s Anesthesia. 30, 825. (Saunders, an imprint of Elsevier Inc., Philadelphia, 2015)"},{"key":"58460_CR23","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s40263-015-0281-8","volume":"29","author":"A Rosati","year":"2015","unstructured":"Rosati, A., De Masi, S. & Guerrini, R. Antiepileptic Drug Treatment in Children with Epilepsy. CNS Drugs. 29, 847\u2013863 (2015).","journal-title":"CNS Drugs."},{"key":"58460_CR24","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1097\/ALN.0000000000002046","volume":"128","author":"R Araki","year":"2018","unstructured":"Araki, R., Hayashi, K. & Sawa, T. Dopamine D2-receptor Antagonist Droperidol Deepens Sevoflurane Anesthesia. Anesthesiology. 128, 754\u2013763 (2018).","journal-title":"Anesthesiology."},{"key":"58460_CR25","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.joms.2012.01.004","volume":"70","author":"S Maeda","year":"2012","unstructured":"Maeda, S. et al. Midazolam is associated with delay in recovery and agitation after ambulatory general anesthesia for dental treatment in patients with disabilities: a retrospective cohort study. J. Oral. Maxillofac. Surg. 70, 1315\u20131320 (2012).","journal-title":"J. Oral. Maxillofac. Surg."},{"key":"58460_CR26","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1097\/00000542-199912000-00052","volume":"91","author":"KK Kaisti","year":"1999","unstructured":"Kaisti, K. K., J\u00e4\u00e4skel\u00e4inen, S. K., Rinne, J. O., Mets\u00e4honkala, L. & Scheinin, H. Epileptiform Discharges during 2 MAC Sevoflurane Anesthesia in Two Healthy Volunteers. Anesthesiology. 91, 1952\u20131955 (1999).","journal-title":"Anesthesiology."},{"key":"58460_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/ANA.0000000000000069","volume":"27","author":"M Smith.","year":"2015","unstructured":"Smith., M., Dobbs, P. & Eapen, G. Abnormal bispectral index values associated with the presence of periodic lateralized epileptiform discharges. J. Neurosurg. Anesthesiol. 27, 73\u201374 (2015).","journal-title":"J. Neurosurg. Anesthesiol."},{"key":"58460_CR28","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1213\/01.ANE.0000117282.72866.26","volume":"98","author":"M Chinzei","year":"2004","unstructured":"Chinzei, M. et al. Change in bispectral index during epileptiform electrical activity under sevoflurane anesthesia in a patient with epilepsy. Anesth. Analg. 98, 1734\u20131736 (2004).","journal-title":"Anesth. Analg."},{"key":"58460_CR29","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/anae.12427","volume":"68","author":"R Bousselmi","year":"2013","unstructured":"Bousselmi, R., Lebbi, A. & Ferjani, M. Bispectral index changes during generalised tonic-clonic seizures. Anaesthesia. 68, 1084\u20131085 (2013).","journal-title":"Anaesthesia."},{"key":"58460_CR30","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4097\/kjae.2013.65.5.449","volume":"65","author":"H Kim","year":"2013","unstructured":"Kim, H. & Kim, S. Y. Pitfall of bispectral index during intraoperative seizure -a case report-. Korean J. Anesthesiol. 65, 449\u2013452 (2013).","journal-title":"Korean J. Anesthesiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58460-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58460-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58460-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T06:35:48Z","timestamp":1670308548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58460-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,31]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["58460"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-58460-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,31]]},"assertion":[{"value":"18 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1578"}}